In this episode, Long-Term Repigmentation Outcomes and Real-World Use of Ruxolitinib Cream, Dr. Desai explores the following ...

One shopper said it gave them “youthful eyes in weeks.” ...

Arcutis Biotherapeutics Inc. (NASDAQ:ARQT) is one of the 10 Overlooked Growth Stocks to Buy Now.

This is highly encouraging news for the millions of men affected by pattern hair loss,” Dr. Joshua Zeichner told The Post.

The American Academy of Dermatology (AAD) released 2 guidelines for the prevention of pediatric atopic dermatitis.

Delgocitinib cream was shown to be effective and well-tolerated in adolescents with chronic hand eczema in the phase 3 DELTA TEEN clinical trial.

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, today announced that VTAMA cream was granted a strong, ...

Tattoo artists across Oregon are voicing concerns after a recent rule clarification from the Oregon Health Authority.

Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”), today announced that CEO ...

The herb, Arnica montana, has been used homeopathically for five centuries, but its modern use focuses on reducing ...

The new guidelines, published in the Journal of the American Academy of Dermatology (JAAD), will guide dermatologists in deciding the best possible prevention and treatment options for pediatric ...

From acne to rosacea, growing evidence shows targeted dermocosmetics can serve as monotherapy for mild disease or as adjunctive care, improving outcomes and treatment tolerability.